ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 6, 2014, Pages 795-806

  Levine, Arie ^a   Koletzko, Sibylle ^b   Turner, Dan ^c   Escher, Johanna C ^d   Cucchiara, Salvatore ^e   De Ridder, Lissy ^d   Kolho, Kaija Leena ^f   Veres, Gabor ^g   Russell, Richard K ^h   Paerregaard, Anders ⁱ   Buderus, Stephan ^j   Greer, Mary Louise C ^k   Dias, Jorge A ^l,m   Veereman Wauters, Gigi ⁿ   Lionetti, Paolo ^o   Sladek, Malgorzata ^p   Martin De Carpi, Javier ^q   Staiano, Annamaria ^r   Ruemmele, Frank M ^s   Wilson, David C ^t  

^a TEL AVIV UNIVERSITY   (Israel)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF HELSINKI   (Finland)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

ⁱ HVIDOVRE HOSPITAL   (Denmark)

^j ST MARIEN HOSPITAL   (Germany)

^k HOSPITAL FOR SICK CHILDREN   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

^m HOSPITAL DE SÃO JOÃO   (Portugal)

ⁿ UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^o UNIVERSITY OF FLORENCE   (Italy)

^p JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^q HOSPITAL SANT JOAN DE DÉU   (Spain)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s UNIVERSITÉ PARIS DESCARTES   (France)

^t UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

Crohn disease; Diagnosis; Inflammatory bowel disease; Inflammatory bowel diseaseunclassified; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT DISEASE; ALGORITHM; ALLERGIC DISEASE; ARTICLE; CAPSULE ENDOSCOPY; CHILDHOOD DISEASE; CLINICAL FEATURE; CONSENSUS; CONTROLLED CLINICAL TRIAL (TOPIC); CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DOUBLE BALLOON ENTEROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY BOWEL DISEASE; INTESTINE ENDOSCOPY; META ANALYSIS (TOPIC); PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); ULCERATIVE COLITIS; ADOLESCENT; CHILD; COLITIS, ULCERATIVE; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; DIGESTIVE TRACT ENDOSCOPY; GASTROINTESTINAL TRACT; INFLAMMATORY BOWEL DISEASES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHENOTYPE; PRACTICE GUIDELINE;

ADOLESCENT; CAPSULE ENDOSCOPY; CHILD; COLITIS, ULCERATIVE; CONSENSUS; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, DIGESTIVE SYSTEM; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE;

EID: 84901638925     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000239     Document Type: Article

References (105)

1. IBD Working Group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: Recommendations for diagnosis-The Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7
2. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114-22
3. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: A population-based cohort study. Gastroenterology 2008;135:1106-13
4. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: A population-based cohort study. Am J Gastroenterol 2009;104:2080-8
5. Levine A, de Bie CL, Turner D, et al. Atypical disease phenotypes in paediatric ulcerative colitis: 5-year analyses of the EUROKIDS registry. Inflamm Bowel Dis 2013;19:370-7
6. Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: Report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007;44:653-74
7. Turner D, Levine A, Escher JC, et al. Joint ECCO and ESPGHAN evidence-based consensus guidelines on the management of pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr 2012;55:340-61
8. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification of inflammatory bowel disease: The Paris classification. Inflamm Bowel Dis 2011;17:1314-21
9. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (suppl A):5-36
10. Gupta N, Bostrom AG, Kirschner BS, et al. Presentation and disease course in early-compared to later-onset pediatric Crohn's disease. Am J Gastroenterol 2008;103:2092-8
11. Guariso G, Gasparetto M, Visona Dalla Pozza L, et al. Inflammatory bowel disease developing in paediatric and adult age. J Pediatr Gastroenterol Nutr 2010;51:698-707
12. Timmer A, Behrens R, Buderus S, et al. Childhood onset inflammatory bowel disease: Predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry. J Pediatr 2011;158:467-473.e2
13. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: A statewide population-based study. J Pediatr 2003;143:525-31. (Pubitemid 37352514)
14. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003;88:995-1000. (Pubitemid 37449406)
15. Jose FA, Garnett EA, Vittinghoff E, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:63-8
16. Stange EF, Travis SP, Vermeire S, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohn's Colitis 2008;2:1-23. (Pubitemid 351179487)
17. Geboes K, Van Eyken P. Inflammatory bowel disease unclassified and indeterminate colitis: The role of the pathologist. J Clin Pathol 2009;62:201-5
18. Glickman JN, Bousvaros A, Farraye FA, et al. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol 2004;28:190-7. (Pubitemid 38124727)
19. Rajwal SR, Puntis JW, McClean P, et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr 2004;38:66-9. (Pubitemid 39274470)
20. Markowitz J, Kahn E, Grancher K, et al. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol 1993;88:2034-7. (Pubitemid 23352167)
21. Kim B, Barnett JL, Kleer CG, et al. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol 1999; 94:3258-62
22. Bernstein CN, Shanahan F, Anton PA, et al. Patchiness of mucosal inflammation in treated ulcerative colitis: A prospective study. Gastrointest Endosc 1995;42:232-7
23. Washington K, Greenson JK, Montgomery E, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol 2002;26:1441-9. (Pubitemid 35239420)
24. Robert ME, Tang L, Hao LM, et al. Patterns of inflammation in mucosal biopsies of ulcerative colitis: Perceived differences in pediatric populations are limited to children younger than 10 years. Am J Surg Pathol 2004;28:183-9. (Pubitemid 38124726)
25. Tobin JM, Sinha B, Ramani P, et al. Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: A blinded, controlled study. J Pediatr Gastroenterol Nutr 2001;32:443-8. (Pubitemid 32488302)
26. Xin W, Greenson JK. The clinical significance of focally enhanced gastritis. Am J Surg Pathol 2004;28:1347-51. (Pubitemid 39336374)
27. Goldstein N, Dulai M. Contemporary morphologic definition of backwash ileitis in ulcerative colitis and features that distinguish it from Crohn disease. Am J Clin Pathol 2006;126:365-76. (Pubitemid 44338788)
28. Haskell H, Andrews CW Jr, Reddy SI, et al. Pathologic features and clinical significance of ''backwash'' ileitis in ulcerative colitis. Am J Surg Pathol 2005;29:1472-81
29. Perisic VN, Filipovic D. Ileoscopy and its clinical role in the assessment of backwash ileitis in children with ulcerative pancolitis: Belgrade experience. J Pediatr Gastroenterol Nutr 1988;7:146-8
30. Newman SL. Ileoscopy, colonoscopy, and backwash ileitis in children with inflammatory bowel disease: Quid pro quö. J Pediatr Gastroenterol Nutr 1987;6:325-7
31. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 (suppl 170):2-6. (Pubitemid 20015811)
32. Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn's disease. Inflamm Bowel Dis 2010;16:332-7
33. Campbell H, Escudier M, Patel P, et al. Distinguishing orofacial granulomatosis from Crohn's disease: Two separate disease entities?. Inflamm Bowel Dis 2011;17:2109-15
34. Keljo DJ, Markowitz J, Langton C, et al. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis 2009;15:383-7
35. Escher JC, Stoof TJ, van Deventer SJH, et al. Successful treatment of metastatic Crohn disease with infliximab. J Pediatr Gastroenterol Nutr 2002;34:420-3. (Pubitemid 34568549)
36. de Bie CL, Paerregaard A, Kolacek S, et al. Disease phenotype at diagnosis in pediatric Crohn's disease: 5 year analyses of the EUROKIDS registry. Inflamm Bowel Dis 2013;19:378-85
37. Rubio CA, Orrego A, Nesi G, et al. Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis. J Clin Pathol 2007;60:1268-72. (Pubitemid 350084550)
38. Matsui T, Yao T, Sakurai T, et al. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation. J Gastroenterol 2003;38:647-55. (Pubitemid 36974978)
39. Alexander F, Sarigol S, DiFiore J, et al. Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg 2003;38:78-82. (Pubitemid 36109892)
40. Melmed GY, Elashoff R, Chen GC, et al. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: A nested, casecontrol study. Clin Gastroenterol Hepatol 2007;5:602-8. (Pubitemid 46671534)
41. Langholz E, Munkholm P, Krasilnikoff PA, et al. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-47. (Pubitemid 27075119)
42. Yantiss RK, Farraye FA, O'Brien MJ, et al. Prognostic significance of superficial fissuring ulceration in patients with severe ''indeterminate'' colitis. Am J Surg Pathol 2006;30:165-70
43. Li DJ, Freeman A, Miles KA, et al. Can 99Tcm HMPAO leucocyte scintigraphy distinguish between Crohn's disease and ulcerative colitis?. Br J Radiol 1994;67:472-7
44. Xin W, Brown PI, Greenson JK. The clinical significance of focal active colitis in pediatric patients. Am J Surg Pathol 2003; 27:1134-8. (Pubitemid 36909535)
45. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9. (Pubitemid 28452928)
46. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999;134:447-52. (Pubitemid 30180626)
47. Markowitz J, Kugathasan S, Dubinsky M, et al. Age of diagnosis influences serologic responses in children with Crohn's disease: A possible clue to etiology?. Inflamm Bowel Dis 2009;15:714-9
48. Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression. Am J Gastroenterol 2006;101:360-7. (Pubitemid 43381681)
49. Russell RK, Ip B, Aldhous MC, et al. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease. J Pediatr Gastroenterol Nutr 2009;48: 161-7
50. Bartu°nková J, Kolárová I, Sedivá A, et al. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Clin Immunol 2002;102:162-8. (Pubitemid 34171515)
51. Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: A prospective follow-up study. Gastroenterology 2002;122:1242-7. (Pubitemid 34465166)
52. Iltanen S, Tervo L, Halttunen T, et al. Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD. Inflamm Bowel Dis 2006;12:389-94
53. Davis MK, Andres JM, Jolley CD, et al. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 2007;45:409-13. (Pubitemid 350307157)
54. Ashorn S, Honkanen T, Kolho KL, et al. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:199-205
55. Mack DR, Langton C, Markowitz J, et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007;119:1113-9. (Pubitemid 46871266)
56. Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis 2008;14:359-66. (Pubitemid 351441325)
57. Sipponen T, Savilahti E, Kolho KL, et al. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008;14:40-6. (Pubitemid 351196867)
58. Shaoul R, Sladek M, Turner D, et al. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease. Inflamm Bowel Dis 2012;18:1493-7
59. Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002;8:325-9
60. Cabrera-Abreu JC, Davies P, Matek Z, et al. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child 2004;89:69-71. (Pubitemid 38122017)
61. Turner D, Mack DR, Hyams J, et al. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both?. A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis 2011;5:423-9
62. Quail MA, Russell RK, Van Limbergen JE, et al. Faecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:756-9
63. Henderson P, Casey A, Lawrence SJ, et al. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2012; 107:941-9
64. Kapel N, Campeotto F, Kalach N, et al. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr 2010;51:542-7
65. Henderson P, Anderson NH, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected paediatric inflammatory bowel disease: A systematic review and meta-Analysis. Am J Gastroenterol 2013doi:10.1038/ajg.2013.131[Epub ahead of print].
66. Trivedi PJ, Chapman RW. PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2012; 36:420-36
67. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136-60
68. de Bie CI, Buderus S, Sandhu BK, et al. Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: Results of a 5-year audit of the EUROKIDS registry. J Pediatr Gastroenterol Nutr 2012;54:374-80
69. van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4:7-27
70. Paerregaard A. What does the IBD patient hide in the upper gastrointestinal tract?. Inflamm Bowel Dis 2009;15:1101-4
71. Lemberg DA, Clarkson CM, Bohane TD, et al. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease. J Gastroenterol Hepatol 2005;20: 1696-700. (Pubitemid 43961075)
72. Haber HP, Busch A, Ziebach R, et al. Bowel wall thickness measured by ultrasound as a marker of Crohn's disease activity in children. Lancet 2000;355:1239-40. (Pubitemid 30184535)
73. Maconi G, Greco S, Duca P, et al. Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease. Inflamm Bowel Dis 2008;14:1555-61
74. Bremner AR, Griffiths M, Argent JD, et al. Sonographic evaluation of inflammatory bowel disease: A prospective, blinded, comparative study. Pediatr Radiol 2006;36:947-53. (Pubitemid 44193157)
75. Migaleddu V, Quaia E, Scanu, et al. Inflammatory activity in Crohn's disease: CE-US. Abdom Imaging 2011;36:142-8
76. Schreyer AG, Geissler A, Albrich H, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol 2004;2:491-7. (Pubitemid 38698365)
77. Chalian M, Ozturk A, Oliva-Hemker M, et al. MR enterography findings of inflammatory bowel disease in pediatric patients. Am J Roentgenol 2011;196:W810-6
78. Durno CA, Sherman P,Williams T, et al. Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2000;30:170-4. (Pubitemid 30366194)
79. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-The-Art MR enterography and CTenterography in small-bowel Crohn's disease. Am J Roentgenol 2009;193:113-21
80. Giles E, Hanci O, McLean A, et al. Optimal assessment of paediatric IBD-A comparison study of MRI and barium follow through. J Paediatr Gastroenterol Nutr 2012;54:758-62
81. Giles E, Barclay AR, Chippington S, et al. Systematic review: MRI for assessment of small bowel disease in paediatric Crohn's disease. Aliment Pharm Ther 2013;37:1121-31
82. Essary B, Kim J, Anupindi S, et al. Pelvic MRI in children with Crohn disease and suspected perianal involvement. Pediatr Radiol 2007; 37:201-8. (Pubitemid 46092112)
83. Liao Z, Gao R, Xu C, et al. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: A systematic review. Gastrointest Endosc 2010;71:280-6
84. Cheifetz AS, Kornbluth AA, Legnani P, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease. Am J Gastroenterol 2006;101:2218-22. (Pubitemid 44477546)
85. Fritscher-Ravens A, Scherbakov P, Bufler P, et al. The feasibility of wireless capsule endoscopy in detecting small intestinal pathology in children under the age of 8 years: A multicentre European study. Gut 2009;58:1467-72
86. Cohen SA, Gralnek IM, Ephrath H, et al. The use of a patency capsule in pediatric Crohn's disease: A prospective evaluation. Dig Dis Sci 2011;56:860-5
87. Cohen SA, Klevens AI. Use of capsule endoscopy in diagnosis and management of pediatric patients, based on meta-Analysis. Clin Gastroenterol Hepatol 2011;9:490-6
88. Guilhon de Araujo Sant'Anna AM, Dubois J, Miron MC, et al. Wireless capsule endoscopy for obscure small-bowel disorders: Final results of the first pediatric controlled trial. Clin Gastroenterol Hepatol 2005;3:264-70. (Pubitemid 40568732)
89. Solem CA, Loftus EV Jr, Fletcher JG, et al. Small-bowel imaging in Crohn's disease: A prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008;68:255-66. (Pubitemid 352024383)
90. Pasha SF, Leighton JA, Das A, et al. Double-balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small-bowel disease: A meta-Analysis. Clin Gastroenterol Hepatol 2008;6:671-6
91. Lin TK, Erdman SH. Double-balloon enteroscopy: Pediatric experience. J Pediatr Gastroenterol Nutr 2010;51:429-32
92. Barth BA, Channabasappa N. Single-balloon enteroscopy in children: Initial experience at a pediatric center. J Pediatr Gastroenterol Nutr 2010;51:680-4
93. Di Nardo G, Oliva S, Aloi M, et al. Usefulness of single-balloon enteroscopy in pediatric Crohn's disease. Gastrointest Endosc 2012;75:80-6
94. de Ridder L, Mensink PB, Lequin MH, et al. Single-balloon enteroscopy, magnetic resonance enterography, and abdominal US useful for evaluation of small-bowel disease in children with (suspected) Crohn's disease. Gastrointest Endosc 2012;75:87-94
95. Ravelli A, Villanacci V, Monfredini C, et al. How patchy is patchy villous atrophy?: Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol 2010;105:2103-10
96. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-28
97. Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-sponsored expert panel report. J Am Diet Assoc 2011;111:17-27
98. Koletzko S, Niggemann B, Arato A, et al. Diagnostic approach and management of cow's-milk protein allergy in infants and children: ESPGHAN GI Committee Practical Guidelines. J Pediatr Gastroenterol Nutr 2012;55:221-9
99. Katsanos KH, Zinovieva E, Lambri E, et al. Eosinophilic-Crohn overlap colitis and review of the literature. J Crohns Colitis 2011;5:256-61
100. Freudenberg F, Wintergerst U, Roesen-Wolff A, et al. Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease. J Allergy Clin Immunol 2010; 125:943-6
101. Horn PC, Belohradsky BH, Urban C, et al. Two new families with Xlinked inhibitor of apoptosis deficiency and a review of all 26 published cases. J Allergy Clin Immunol 2011;127:544-6
102. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033-45
103. Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: Implications for diagnosis and therapy. Gastroenterol 2012;143:347-55
104. Verdonk RC, Dijkstra G, Haagsma EB, et al. Inflammatory bowel disease after liver transplantation: Risk factors for recurrence and de novo disease. Am J Transplant 2006;6:1422-9. (Pubitemid 44030325)
105. Dehghani SM, Eshraghian A, Bahador A, et al. De novo inflammatory bowel disease after pediatric orthotopic liver transplant: A case report. Exp Clin Transplant 2009;7:145-8.